A detailed history of Logos Global Management LP transactions in Compass Pathways PLC stock. As of the latest transaction made, Logos Global Management LP holds 1,159,030 shares of CMPS stock, worth $9.9 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
1,159,030
Previous 1,159,030 -0.0%
Holding current value
$9.9 Million
Previous $9.9 Million -0.0%
% of portfolio
1.31%
Previous 0.93%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
N/A
901,050 Added 349.27%
1,159,030 $9.9 Million
Q1 2024

May 15, 2024

SELL
N/A
-242,020 Reduced 48.4%
257,980 $2.2 Million
Q4 2023

Feb 14, 2024

SELL
N/A
-450,000 Reduced 47.37%
500,000 $4.27 Million
Q3 2023

Nov 14, 2023

BUY
N/A
950,000 New
950,000 $8.11 Million
Q3 2022

Nov 14, 2022

BUY
$10.73 - $20.07 $5.47 Million - $10.2 Million
510,000 New
510,000 $5.47 Million
Q1 2022

May 16, 2022

SELL
$11.13 - $23.04 $3.34 Million - $6.91 Million
-300,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$21.81 - $48.96 $24 Million - $53.9 Million
-1,100,000 Reduced 78.57%
300,000 $6.63 Million
Q3 2021

Nov 15, 2021

BUY
$29.03 - $38.62 $16 Million - $21.2 Million
550,000 Added 64.71%
1,400,000 $41.8 Million
Q2 2021

Aug 16, 2021

BUY
$32.29 - $39.68 $19.4 Million - $23.8 Million
600,000 Added 240.0%
850,000 $32.4 Million
Q1 2021

May 17, 2021

SELL
$34.75 - $57.5 $1.74 Million - $2.88 Million
-50,000 Reduced 16.67%
250,000 $9.21 Million
Q4 2020

Feb 16, 2021

SELL
$32.0 - $59.2 $6.4 Million - $11.8 Million
-200,000 Reduced 40.0%
300,000 $14.3 Million
Q3 2020

Nov 16, 2020

BUY
$28.83 - $43.17 $14.4 Million - $21.6 Million
500,000 New
500,000 $17.5 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.